Baby's Diet Could Cut Lifetime Odds for Crohn's, Colitis
WEDNESDAY, Jan. 31, 2024 -- Toddlers are famously picky eaters, but parents may be doing their young child ' s future gut a huge favor if they insist on a healthy diet.
New research shows that toddlers who eat plenty of fish and vegetables, and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 31, 2024 Category: General Medicine Source Type: news
Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn's
(MedPage Today) -- LAS VEGAS -- Children and teens with Crohn's disease who received early tumor necrosis antagonist (anti-TNF) treatment had a lower risk of developing perianal fistulizing complications (PFCs) than those who received no immunosuppression... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 28, 2024 Category: Gastroenterology Source Type: news
3 Dividend Stars Every Investor Should Own to Survive a Market Crash
Income investors will appreciate these three stalwarts for an economy that lands harder than anticipated. One of the best reasons to invest in dividend stocks is how well they hold up when the stock market falls. Whether it’s a correction, a bear market, a recession, a depression or a full-on…#hartford #abbvie #humira #rinvoq #crohn #healthcare #ntforego #abbv #americanstateswater #dividendking (Source: Reuters: Health)
Source: Reuters: Health - January 25, 2024 Category: Consumer Health News Source Type: news
Biomarkers Have a Clear Role in Managing Crohn's Disease Biomarkers Have a Clear Role in Managing Crohn's Disease
Ashwin Ananthakrishnan, MD, lead author of the new AGA guidelines, discussed using biomarkers over endoscopy in monitoring treatment response among specific types of CD.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 23, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
RCSI joins Limerick ’s Serosep to tackle ulcerative colitis
RCSI and Serosep aim to find biomarkers that can predict the progression of the inflammatory bowel disease, to improve treatment options for patients. The Royal College of Surgeons in Ireland (RCSI) has partnered with Irish diagnostics company Serosep to personalise treatment for ulcerative…#rcsi #ireland #irish #serosep #limerick #crohn #5aminosalicylates #sudiptodas #das #clinicians (Source: Reuters: Health)
Source: Reuters: Health - January 23, 2024 Category: Consumer Health News Source Type: news
Understanding and Addressing Crohn's and Colitis
Introduction Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel diseases (IBD), disproportionately affect the Western world, particularly North America. These autoimmune diseases present a significant challenge to those diagnosed, often leading to severe pain and…#crohn #alberta #calgary #banffnationalpark #highland #holisticnutrition #globalpractice #diet #joshdechs #gutsolutionca (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2024 Category: Consumer Health News Source Type: news
New American Gastroenterological Association Guidelines for Managing Crohn ’s Disease Suggest More Clinical Laboratory Tests and Fewer Colonoscopies
As doctors become more familiar with using biomarkers to monitor Crohn’s disease, clinical laboratories may play a greater role in that process New evidence-based guidelines from the American Gastroenterological Association (AGA) that call for using specific biomarkers to help manage Crohn’s disease (CD) may decrease the number of invasive procedures patients must undergo and increase […]
The post New American Gastroenterological Association Guidelines for Managing Crohn’s Disease Suggest More Clinical Laboratory Tests and Fewer Colonoscopies appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - January 12, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine AGA American Gastroenterological Association anatomic pathology Ashkan Farhadi MD Ashwin Ananthakrishnan MD biomarkers c reactive protein Source Type: news
Crohn's, Colitis Vary by Race, Gender
FRIDAY, Jan. 5, 2023 -- Crohn ' s disease and ulcerative colitis show different patterns of incidence by race, gender and even place of birth, a new U.S. study finds.
The two illnesses are each classified as an inflammatory bowel disorder (IBD) --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 5, 2024 Category: General Medicine Source Type: news
Clinical Challenges: Integrating Diet Into Crohn's Disease Management
(MedPage Today) -- Incorporating diet into Crohn's disease (CD) treatment regimens has some support, with a shift toward a whole-foods nutrition approach for symptom relief and healing.
Although far from definitively established, inflammation... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 27, 2023 Category: Gastroenterology Source Type: news
The Most Exciting New Advancements in Managing and Treating Lupus
The case study involved just one patient: a 20-year-old woman with severe systemic lupus erythematosus (SLE). But the study’s results were so dramatic that they appeared in 2021 in the New England Journal of Medicine.
The woman received a type of cell therapy called CAR-T, which in the past has been used primarily to treat cancer. CAR-T cell therapy involves altering a patient’s immune cells so that they identify and attack problems or pathogens. In people with cancer, that attack is aimed at the diseased cells. But in the NEJM case study, the therapy was directed at the woman’s own B cells,...
Source: TIME: Health - December 27, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news
Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in Japan
Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Media News - December 19, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Investor Update - December 19, 2023 Category: Pharmaceuticals Source Type: news
6 Myths About IBD, Debunked
Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes with work at a design studio became an extreme exercise in perseverance. She knew in her gut that something was wrong.
Yet three different doctors “wrote it off as stress,” says Pickens, now 32, who lives in Annapolis, Md. Lab work and procedures to see inside her gastrointestinal tract showed nothing abnormal. “No one wanted to dig deeper,” she recalls. In a final act of desperation, Pickens sa...
Source: TIME: Health - December 18, 2023 Category: Consumer Health News Authors: Lindsay Lyon Tags: Uncategorized healthscienceclimate Source Type: news
Goodbye, Appendix. Hello, Crohn's Disease?
(MedPage Today) -- ORLANDO – People who undergo appendectomy may have an increased risk for the development of Crohn's disease (CD), but not ulcerative colitis (UC), according to a systematic review and meta-analysis.
The meta-analysis showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
